http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2554212-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c010e07a120306054c60efff15382c7e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
filingDate 2014-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d49b994ce9bc8268d3ea18090a98f19b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f87779507d17e28fd7115b18997ce318
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8021967670765525d26545fee08bd6c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78ef95f45deae912be5bded45b41fbf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbae47c2822fe694bf4dc70fb1eb3806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d87c94672c3f194f58f94758af7c9167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a161c5c63922402e2037f741b454b861
publicationDate 2015-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2554212-C1
titleOfInvention Method of evaluating efficiency of radiofrequency ablation of renal arteries in patients with resistant arterial hypertension
abstract FIELD: medicine. n SUBSTANCE: invention is intended for visualisation of regions of local myocardium dystrophy in evaluating efficiency of radiofrequency ablation (RFA) of renal arteries in patients with resistant arterial hypertension. Before and after RFA T1-weighed spin-echo ECG-synchronised MRI of heart is conducted by cuts on short axis of left ventricle 7-8 mm thick 8-15 min after introduction of contrast paramagnetic substance in dose 2 ml of 0.5 M solution per 10 kg of body weight. Volume of contrast inclusion into myocardium and in case of its reduction by value less than 1 cm 3 in comparison with value of said index before RFA, RFA is evaluated as effective. n EFFECT: method ensures clear visualisation of myocardium injury areas, their extension and localisation. n 5 dwg, 1 tbl, 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2728093-C1
priorityDate 2014-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011139589-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2494773-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2487686-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24838310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450360487

Total number of triples: 25.